Back to Menu
1. Clinical presentation assessment
Evaluate lymph nodes, liver and spleen, and B symptoms. Painless progressive enlargement is an important warning sign.
2. Pathological biopsy diagnosis
Complete excision of an involved lymph node for pathological examination is the gold standard and is essential for subtype classification and treatment decision-making.
3. Imaging examinations
CT and PET-CT are used for accurate staging and treatment response assessment and help guide treatment strategy.
4. Bone marrow examination
Bone marrow aspiration and biopsy determine whether marrow involvement is present and are important for staging and prognostic evaluation.
5. Laboratory tests
Tests such as complete blood count, LDH, and β2-microglobulin help assess overall condition and support prognostic assessment.
6. Immunophenotypic analysis
Flow cytometry or immunohistochemistry distinguishes B-, T-, or NK-cell origin, enabling precise classification that determines therapy.
7. Molecular genetic testing
FISH or sequencing detects genetic abnormalities, providing prognostic information and potential therapeutic targets.
8. Use of staging systems
Ann Arbor staging combined with prognostic indices guides formulation of individualized treatment plans.
9. Daily self-check for lymphoma
Check lymph node regions monthly and pay attention to fever, night sweats, and weight loss; seek medical evaluation promptly if abnormalities appear.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that lymphoma is a heterogeneous malignant disease with a complex diagnostic process and significant health impact. Early diagnosis and precise classification are key to improving cure rates. Standardized and systematic diagnostic evaluation provides the basis for individualized treatment. The public should remain alert to early warning signs such as painless lymph node enlargement, undergo regular health examinations, and seek timely medical evaluation to secure the best treatment opportunity.
1. Clinical presentation assessment
Evaluate lymph nodes, liver and spleen, and B symptoms. Painless progressive enlargement is an important warning sign.
2. Pathological biopsy diagnosis
Complete excision of an involved lymph node for pathological examination is the gold standard and is essential for subtype classification and treatment decision-making.
3. Imaging examinations
CT and PET-CT are used for accurate staging and treatment response assessment and help guide treatment strategy.
4. Bone marrow examination
Bone marrow aspiration and biopsy determine whether marrow involvement is present and are important for staging and prognostic evaluation.
5. Laboratory tests
Tests such as complete blood count, LDH, and β2-microglobulin help assess overall condition and support prognostic assessment.
6. Immunophenotypic analysis
Flow cytometry or immunohistochemistry distinguishes B-, T-, or NK-cell origin, enabling precise classification that determines therapy.
7. Molecular genetic testing
FISH or sequencing detects genetic abnormalities, providing prognostic information and potential therapeutic targets.
8. Use of staging systems
Ann Arbor staging combined with prognostic indices guides formulation of individualized treatment plans.
9. Daily self-check for lymphoma
Check lymph node regions monthly and pay attention to fever, night sweats, and weight loss; seek medical evaluation promptly if abnormalities appear.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that lymphoma is a heterogeneous malignant disease with a complex diagnostic process and significant health impact. Early diagnosis and precise classification are key to improving cure rates. Standardized and systematic diagnostic evaluation provides the basis for individualized treatment. The public should remain alert to early warning signs such as painless lymph node enlargement, undergo regular health examinations, and seek timely medical evaluation to secure the best treatment opportunity.